In this issue of Clinics in Chest Medicine, guest editors Drs. Clemente J. Britto and Jennifer L. Taylor-Cousar bring their considerable expertise to Advances in Cystic Fibrosis. Top experts in the field cover key topics such as genetics of cystic fibrosis (CF):: clinical implications; innate and adaptive immunity in CF; novel applications of biomarkers and personalized medicine to define the spectrum of CF; emerging approaches to understand CF pathogenesis; and more.
Toward a Broader Understanding of Cystic Fibrosis Epidemiology and Its Impact on Clinical Manifestations Genetics of Cystic Fibrosis: Clinical Implications Update on Innate and Adaptive Immunity in Cystic Fibrosis Novel Applications of Biomarkers and Personalized Medicine in Cystic Fibrosis Emerging Approaches to Monitor and Modify Care in the Era of Cystic Fibrosis Transmembrane Conductance Regulators The Impact of Highly Effective Modulator Therapy on Cystic Fibrosis Microbiology and Inflammation Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis Update on Clinical Outcomes of Highly Effective Modulator Therapy Nontuberculous Mycobacterial Infections in Cystic Fibrosis Non-Modulator Therapies: Developing a Therapy for Every Cystic Fibrosis Patient Updates in Nutrition Management of Cystic Fibrosis in the Highly Effective Modulator Era Update in Advancing the Gastrointestinal Frontier in Cystic Fibrosis Transitions of Care in Cystic Fibrosis Endocrine Complications of Cystic Fibrosis Management of Mental Health in Cystic Fibrosis Family Planning and Reproductive Health in Cystic Fibrosis Update on Lung Transplantation for Cystic Fibrosis
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.